Preliminary application of next-generation Ion Torrent PMGTM platform on genetic diseases in pediatrics

Lin YANG,Hui-jun WANG,Bai-lin WU,Guo-ying HUANG,Wen-hao ZHOU,Xiao-hong GUO

DOI: https://doi.org/10.3969/j.issn.1673-5501.2013.03.011

2013-01-01

Abstract:Objective Our study aimed to assess the efficiency and reliability of clinical genetic diagnosis as a new approach for genetic diseases using the next-generation Ion Torrent PGM sequencing platform in pediatrics.Methods Four unrelated patients with clinical signs of Duchenne/Becker muscular dystrophy (case 1 and case 2), bile acid synthesis defect (case 3) and methylmalonic academia (case 4) were recruited. DNA from the patients was screened using Ion Torrent PGMTM platform, and the results were compared with those obtained by dideoxy sequencing or multiplex ligation-dependent probe amplification analysis.Results Case 1: Six variants were identified by Ion Torrent PGMTM in the coding region of DMD gene, including 4 SNPs (rs228406, rs1801187, rs1801188, rs1800280), one causal mutation (c.998C>A, p.333S>X) and one insertion (c.10127insT, FS). All variants were confirmed by dideoxy sequencing except the insertion (c.10127insT). Case 2: A five-exonic deletion was detected by Ion Torrent PGM in the DMD gene and confirmed by multiplex ligation-dependent probe amplification. Case 3: Seven variants were identified by Ion Torrent PGMTM in the coding region of HSD3B7 and AMACR genes, including 2 compound heterozygous mutations (c.45-46delAG, FS; c.262G>G/C, p.88G>RG), 5 SNPs (rs9938550, rs3195676, rs10941112, rs2278008, rs2287939). All variants were confirmed by dideoxy sequencing. Case 4: Three variants were identified by Ion Torrent PGMTM in the coding region of MUT gene,including one heterozygous mutation (c.729-730het-insTT, FS), 2 SNPs (rs2229384, rs8589). These variants were confirmed by dideoxy sequencing. Two variants (c.1595C>CT, p.532R>RH; c.1540G>GT, p.514Q>KQ) were detected by Ion Torrent only.Conclusions Here the implementation of Next-generation Ion Torrent Sequencing is discussed. This platform can be readily adopted by clinical molecular testing laboratories and represents a rapid, cost-effective, high throughput approach for screening common genetic diseases.